API

sh-oligopeptide-1

Original EGF with clinically proven safety and effectiveness
Results of 22 years of research by Daewoong Pharmaceutical, We introduced the outstanding EGF, which has acquired 34 patents in 23 countries.

The same EGF as the human body of pharmaceutical standard,
EGF with high safety and high purity

The same EGF as the treatment for diabetic wound of Daewoong Pharmaceutical (EGF external solution – world’s first EGF biotechnology new drug No. 1)

Safety and efficacy have been proved in clinic by eliminating various microbial contamination sources and allergen impurities

Product sh-oligopeptide-1(DW-EGF)
Drug Specification(Daewoong)
Competitors’ EGF
Cosmetic Specifications(Third Party)
Purity 98%
(HPLC-purity measurement)
90%
(SDS page-protein molecular weight measurement method)
Safety Has impurity criteria
– Host-derived protein / DNA, – Endotoxin 0 / Aseptic
Does not have impurity criteria
Vitality 1,200,000IU/mg (cell active)
ED50: 23~33pg/ml
800,000IU/mg
(Method for measuring cytotoxicity)

Safe for damaged skin as well as healthy skin

Derma Pro test results: excellent improvement in eye wrinkles after 4 weeks of use

nep_img01

Dayi Corp. Test results: Helps maintain skin elasticity, lipid and moisture after 4 weeks of use

nep_img02

Registered EGF as the world’s first in International Cosmetic Ingredient Specification Collection and acquired WHO general name

General Name: sh-oligopeptide-1(DW-EGF) [WHO Drug Information (2008), 22(1):59]

International cosmetic raw material specification name : DW EGF [CTFA Monograph ID : 12550] (ICID 9th edition, 2002)

nep_img03

About 10 times more active than cosmetic ingredients

Promoting cell migration and epithelial / endothelial cell migration and proliferation with the same level of activity as Standard EGF

nep_img04

Daewoong Pharmaceutical Manufacturing

With the only GMP facility in Korea unlike other companies, it can produce natural EGF in synthetic form without refolding / cell disruption in the production process, and can supply uniform quality and stable supply.

nep_img05

The only “EGF Cosmetic Quality Inspection Commission” agency (2005) approved by KFDA

DNCompany: The only company in Korea to hold EGF functional cosmetics (Easydew EX 1, Cellisys EX 1): Wrinkle functions approved by KFDA

Acquired 34 patents from 23 countries including USA, Europe, Japan

With the only GMP facility in Korea unlike other companies, it can produce natural EGF in synthetic form without refolding / cell disruption in the production process, and can supply uniform quality and stable supply.

nep_img06

Nanoliposome Patented Technology to enhance EGF skin absorption & maximize safety

Skin penetration of nanoliposome sh-oligopeptiode-1(DW-EGF) is increased more than 3 times when applied to skin.

nep_img07